Drs Camidge and Clackson discussed Dr Clackson’s career journey through the biotechnology field, which began with a curiosity about biology and evolution.
Tim Clackson, PhD
Advertisement
Tim Clackson, PhD, is a biotechnology executive at Kesmalea Therapeutics.
Articles by Tim Clackson, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Rituximab Biosimilar for Hematologic Malignancies
2
Talk of Cure, a New ADC, and a Negative Trial: Breaking Down the Biggest Gynecologic Cancer News From ASCO 2026
3
Emerging Maintenance Strategies May be the Key to Extending Survival in ES-SCLC
4
Phase 1 Data Set the Stage for Further Exploration of Cevostamab in R/R Myeloma
5